FEBUXOSTAT 80 mg.
Febuxostat 80 mg is a xanthine oxidase inhibitor used for the long-term management of elevated uric acid levels in patients with gout. It works by reducing the production of uric acid in the body, helping prevent the formation of urate crystals that can lead to painful gout attacks and joint damage. The medication is effective in maintaining healthy uric acid levels and supporting overall joint health.
Benefits:
- Effectively lowers elevated blood uric acid levels
- Helps prevent recurrent gout attacks and flare-ups
- Reduces the risk of uric acid crystal deposition in joints and tissues
- Supports long-term management of chronic gout
- Helps protect joints from gout-related damage and inflammation
- Convenient once-daily dosing for improved patient compliance
Indications:
Febuxostat 80 mg is indicated for:
- Chronic management of hyperuricemia (high uric acid levels) in patients with gout
- Prevention of gout flare-ups associated with elevated uric acid levels
- Reduction of urate crystal accumulation in joints and tissues
- Long-term treatment of gout in patients requiring uric acid-lowering therapy
